Who is this study for: Patients with Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia
Status: Recruiting
Start Date: January 25, 2021
Intervention Type: Drug, Radiation, Procedure, Biological
Study Drugs: Sargramostim, Fludarabine, Cyclosporine, Mycophenolate Mofetil, Mycophenolic
Phase: Phase 2